Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 18;10(6):1019-1020.
doi: 10.18240/ijo.2017.06.31. eCollection 2017.

Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye

Seung Min Lee  1   2 , Jae Woo Jung  1   2 , Sung Who Park  2   3 , Ji Eun Lee  2   3 , Ik Soo Byon  1   2
Affiliations

Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye

Seung Min Lee et al. Int J Ophthalmol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Three days after surgery, the vitreous hemorrhage had resolved
Removed neovascular membrane, coagulated retinal vessel and retinal burns from laser photocoagulation were observed.
Figure 2
Figure 2. Before and after Ozurdex® implant injection
A: A wide-field fundus photograph showing photocoagulation scars in the area of the superior BRVO; B: Swept-source optical coherence tomography image showing cystoid ME; C: Following injection, the Ozurdex® implant was observed lodged in the inferior retina (white arrow); D: Three months later, implant had disappeared and a barrier photocoagulation scar around the bare sclera was seen. Retinal detachment did not occur.
See this image and copyright information in PMC

References

    1. Haller JA, Bandello F, Belfort R, Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117(6):1134–1146. - PubMed
    1. Heng LZ, Sivaprasad S, Crosby-Nwaobi R, Saihan Z, Karampelas M, Bunce C, Peto T, Hykin PG. A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study) Br J Ophthalmol. 2016;100(6):802–807. - PubMed
    1. Berarducci A, Sian IS, Ling R. Inadvertent dexamethasone implant injection into the lens body management. Eur J Ophthalmol. 2014;24(4):620–622. - PubMed
    1. Coca-Robinot J, Casco-Silva B, Armadá-Maresca F, García-Martínez J. Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens. Eur J Ophthalmol. 2014;24(4):633–636. - PubMed
    1. Bishop P. The biochemical structure of the mammalian vitreous. Eye(Lond) 1996;10(Pt 6):664–670. - PubMed

LinkOut - more resources